Holdings of iShares Health Innovation Active ETF
BlackRock ETF Trust · 45 declared positions · as of Apr 30, 2026
Original filing · Net assets 10.1M $ · Ten largest lines: 44.6 % of the equity sleeve
Sector breakdown
- Health care 48.6 %
- Unattributed 51.4 %
Sector is not declared in Form N-PORT: this is a Titelia classification, decided company by company. The unattributed share is counted as such rather than spread over the others.
Currency breakdown
- USD 90.7 %
- CHF 4.3 %
- HKD 3.4 %
- EUR 1.7 %
The currency each line is denominated in, as declared. It does not follow the country: a French company listed in the United States is declared in dollars.
Country breakdown
- US 81.0 %
- CH 5.4 %
- GB 3.8 %
- HK 3.4 %
- NL 3.0 %
- BE 1.7 %
- IL 1.2 %
- DE 0.5 %
Shares computed on the equity sleeve, the only part this site carries.
| Country | Lines | Value (USD) | Share |
|---|---|---|---|
| US | 35 | 7.8M $ | 81.04 % |
| CH | 3 | 516.9K $ | 5.36 % |
| GB | 2 | 369.3K $ | 3.83 % |
| HK | 1 | 324.7K $ | 3.37 % |
| NL | 1 | 287.7K $ | 2.98 % |
| BE | 1 | 159.6K $ | 1.65 % |
| IL | 1 | 118.7K $ | 1.23 % |
| DE | 1 | 52.4K $ | 0.54 % |
Positions
| Company | Shares | Value (USD) | Weight |
|---|---|---|---|
| Johnson & Johnson | 3,459 | 795.1K $ | 7.88 % |
| Gilead Sciences Inc | 4,165 | 544.9K $ | 5.40 % |
| Edwards Lifesciences Corp | 5,726 | 478.1K $ | 4.74 % |
| Amgen Inc | 1,342 | 464.7K $ | 4.60 % |
| Merck & Co Inc | 3,620 | 395.2K $ | 3.92 % |
| Biogen Inc | 1,935 | 366.3K $ | 3.63 % |
| Wuxi Biologics Cayman Inc | 76,000 | 324.7K $ | 3.22 % |
| Waters Corp | 1,035 | 320.1K $ | 3.17 % |
| Mettler-Toledo International Inc | 245 | 312.8K $ | 3.10 % |
| Intuitive Surgical Inc | 651 | 297.9K $ | 2.95 % |
| Charles River Laboratories International Inc | 1,783 | 297.7K $ | 2.95 % |
| Vertex Pharmaceuticals Inc | 690 | 294.9K $ | 2.92 % |
| Argenx SE | 368 | 287.7K $ | 2.85 % |
| Moderna Inc | 5,804 | 266.6K $ | 2.64 % |
| Pfizer Inc | 9,393 | 250.8K $ | 2.48 % |
| Danaher Corp | 1,398 | 250.2K $ | 2.48 % |
| Bruker Corp | 6,389 | 234.5K $ | 2.32 % |
| Novartis AG | 1,579 | 233.4K $ | 2.31 % |
| Bio-Techne Corp | 3,805 | 210.5K $ | 2.09 % |
| Dexcom Inc | 3,493 | 208K $ | 2.06 % |
| GSK PLC | 3,926 | 205.4K $ | 2.03 % |
| Protagonist Therapeutics Inc | 2,031 | 201K $ | 1.99 % |
| Thermo Fisher Scientific Inc | 408 | 195.4K $ | 1.94 % |
| Roche Holding AG | 446 | 181.7K $ | 1.80 % |
| Insmed Inc | 1,326 | 180.8K $ | 1.79 % |
| AstraZeneca PLC | 875 | 163.9K $ | 1.62 % |
| UCB SA | 586 | 159.6K $ | 1.58 % |
| Cogent Biosciences Inc | 4,393 | 157.2K $ | 1.56 % |
| Incyte Corp | 1,645 | 156.7K $ | 1.55 % |
| IDEXX Laboratories Inc | 256 | 143.6K $ | 1.42 % |
| Boston Scientific Corp | 2,435 | 140.3K $ | 1.39 % |
| Bristol-Myers Squibb Co | 2,169 | 131.4K $ | 1.30 % |
| BioMarin Pharmaceutical Inc | 2,280 | 122.9K $ | 1.22 % |
| Teva Pharmaceutical Industries Ltd | 3,386 | 118.7K $ | 1.18 % |
| Revolution Medicines Inc | 723 | 104.2K $ | 1.03 % |
| Alcon AG | 1,360 | 101.8K $ | 1.01 % |
| Summit Therapeutics Inc | 3,507 | 75.3K $ | 0.75 % |
| Medline Inc | 1,459 | 64.9K $ | 0.64 % |
| Dianthus Therapeutics Inc | 651 | 57.2K $ | 0.57 % |
| BioNTech SE | 507 | 52.4K $ | 0.52 % |
| Apogee Therapeutics Inc | 576 | 47.7K $ | 0.47 % |
| Sagimet Biosciences Inc | 1,688 | 13.6K $ | 0.13 % |
| Erasca Inc | 1,251 | 13.3K $ | 0.13 % |
| Eikon Therapeutics Inc | 1,253 | 12K $ | 0.12 % |
| Ultragenyx Pharmaceutical Inc | 460 | 11.4K $ | 0.11 % |